Dystonia: Are animal models relevant in therapeutics?

M. Meringolo, A. Tassone, P. Imbriani, G. Ponterio, A. Pisani

Research output: Contribution to journalArticle

Abstract

Dystonia refers to a heterogeneous group of movement disorders characterized by involuntary, sustained muscle contractions leading to repetitive twisting movements and abnormal postures. A better understanding of the etiology, pathogenesis and molecular mechanisms underlying dystonia may be obtained from animal models. Indeed, while studies in vitro using cell and tissue models are helpful for investigating molecular pathways, animal models remain essential for studying the pathogenesis of these disorders and exploring new potential treatment strategies. To date, the mouse is the most common choice for mammalian models in most laboratories, particularly when manipulations of the genome are planned. Dystonia animal models can be classified into two categories, etiological and symptomatic, although neither is able to recapitulate all features of these disorders in humans. Nevertheless, etiological and symptomatic animal models have advantages and limitations that should be taken into consideration according to the specific proposed hypothesis and experimental goals. Etiological mouse models of inherited dystonia can reproduce the etiology of the disorder and help to reveal biochemical and cellular alterations, although a large majority of them lack motor symptoms. Conversely, symptomatic models can partially mimic the phenotype of human dystonia and test novel pharmacological agents, and also identify the anatomical and physiological processes involved, although the etiology remains unknown. Thus, our brief survey aims to review the state of the art as regards most of the commonly used animal models available for dystonia research.

Original languageEnglish
JournalRevue Neurologique
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Dystonia
Animal Models
Therapeutics
Physiological Phenomena
Dyskinesias
Movement Disorders
Muscle Contraction
Posture
Smooth Muscle
Genome
Pharmacology
Phenotype
Research

Keywords

  • Animal models
  • Cholinergic interneurons
  • Dystonia
  • DYT1
  • Therapeutics

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Dystonia : Are animal models relevant in therapeutics? / Meringolo, M.; Tassone, A.; Imbriani, P.; Ponterio, G.; Pisani, A.

In: Revue Neurologique, 01.01.2018.

Research output: Contribution to journalArticle

Meringolo, M. ; Tassone, A. ; Imbriani, P. ; Ponterio, G. ; Pisani, A. / Dystonia : Are animal models relevant in therapeutics?. In: Revue Neurologique. 2018.
@article{1ad3765255d74ab78a747b61d474fae6,
title = "Dystonia: Are animal models relevant in therapeutics?",
abstract = "Dystonia refers to a heterogeneous group of movement disorders characterized by involuntary, sustained muscle contractions leading to repetitive twisting movements and abnormal postures. A better understanding of the etiology, pathogenesis and molecular mechanisms underlying dystonia may be obtained from animal models. Indeed, while studies in vitro using cell and tissue models are helpful for investigating molecular pathways, animal models remain essential for studying the pathogenesis of these disorders and exploring new potential treatment strategies. To date, the mouse is the most common choice for mammalian models in most laboratories, particularly when manipulations of the genome are planned. Dystonia animal models can be classified into two categories, etiological and symptomatic, although neither is able to recapitulate all features of these disorders in humans. Nevertheless, etiological and symptomatic animal models have advantages and limitations that should be taken into consideration according to the specific proposed hypothesis and experimental goals. Etiological mouse models of inherited dystonia can reproduce the etiology of the disorder and help to reveal biochemical and cellular alterations, although a large majority of them lack motor symptoms. Conversely, symptomatic models can partially mimic the phenotype of human dystonia and test novel pharmacological agents, and also identify the anatomical and physiological processes involved, although the etiology remains unknown. Thus, our brief survey aims to review the state of the art as regards most of the commonly used animal models available for dystonia research.",
keywords = "Animal models, Cholinergic interneurons, Dystonia, DYT1, Therapeutics",
author = "M. Meringolo and A. Tassone and P. Imbriani and G. Ponterio and A. Pisani",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.neurol.2018.07.003",
language = "English",
journal = "Revue Neurologique",
issn = "0035-3787",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Dystonia

T2 - Are animal models relevant in therapeutics?

AU - Meringolo, M.

AU - Tassone, A.

AU - Imbriani, P.

AU - Ponterio, G.

AU - Pisani, A.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Dystonia refers to a heterogeneous group of movement disorders characterized by involuntary, sustained muscle contractions leading to repetitive twisting movements and abnormal postures. A better understanding of the etiology, pathogenesis and molecular mechanisms underlying dystonia may be obtained from animal models. Indeed, while studies in vitro using cell and tissue models are helpful for investigating molecular pathways, animal models remain essential for studying the pathogenesis of these disorders and exploring new potential treatment strategies. To date, the mouse is the most common choice for mammalian models in most laboratories, particularly when manipulations of the genome are planned. Dystonia animal models can be classified into two categories, etiological and symptomatic, although neither is able to recapitulate all features of these disorders in humans. Nevertheless, etiological and symptomatic animal models have advantages and limitations that should be taken into consideration according to the specific proposed hypothesis and experimental goals. Etiological mouse models of inherited dystonia can reproduce the etiology of the disorder and help to reveal biochemical and cellular alterations, although a large majority of them lack motor symptoms. Conversely, symptomatic models can partially mimic the phenotype of human dystonia and test novel pharmacological agents, and also identify the anatomical and physiological processes involved, although the etiology remains unknown. Thus, our brief survey aims to review the state of the art as regards most of the commonly used animal models available for dystonia research.

AB - Dystonia refers to a heterogeneous group of movement disorders characterized by involuntary, sustained muscle contractions leading to repetitive twisting movements and abnormal postures. A better understanding of the etiology, pathogenesis and molecular mechanisms underlying dystonia may be obtained from animal models. Indeed, while studies in vitro using cell and tissue models are helpful for investigating molecular pathways, animal models remain essential for studying the pathogenesis of these disorders and exploring new potential treatment strategies. To date, the mouse is the most common choice for mammalian models in most laboratories, particularly when manipulations of the genome are planned. Dystonia animal models can be classified into two categories, etiological and symptomatic, although neither is able to recapitulate all features of these disorders in humans. Nevertheless, etiological and symptomatic animal models have advantages and limitations that should be taken into consideration according to the specific proposed hypothesis and experimental goals. Etiological mouse models of inherited dystonia can reproduce the etiology of the disorder and help to reveal biochemical and cellular alterations, although a large majority of them lack motor symptoms. Conversely, symptomatic models can partially mimic the phenotype of human dystonia and test novel pharmacological agents, and also identify the anatomical and physiological processes involved, although the etiology remains unknown. Thus, our brief survey aims to review the state of the art as regards most of the commonly used animal models available for dystonia research.

KW - Animal models

KW - Cholinergic interneurons

KW - Dystonia

KW - DYT1

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85054324400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054324400&partnerID=8YFLogxK

U2 - 10.1016/j.neurol.2018.07.003

DO - 10.1016/j.neurol.2018.07.003

M3 - Article

AN - SCOPUS:85054324400

JO - Revue Neurologique

JF - Revue Neurologique

SN - 0035-3787

ER -